Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42. Daniel covers the ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. President Trump announced new tariffs on generic drugs, effective August 1, 2026, starting ...

Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...

In an era of escalating healthcare costs, Americans increasingly face crucial decisions about their prescription medications. The choice between generic and brand-name drugs represents a significant ...

Ottawa, Precedence Research, April 16, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the worldwide generic drugs market size was valued at USD 445.62 billion in 2024 and is projected to ...

Emory is the data editor at STAT. He’s a data journalist with a background in bioinformatics and molecular biology. You can reach Emory on Signal at jaspar.01. Elaine’s stories explore the boom in new ...

A preliminary study of 52,330 Israeli women found similar rates of heart attack, stroke, blood clots and early death among hormone therapy users and nonusers, though it cannot prove safety. Older ...

The most common prescription drugs you pick up at the pharmacy counter or fill via mail order will likely get more expensive under President Donald Trump's plan to assess a 100% tariff on imported ...

Generic drugs manufactured in India are linked to significantly more "severe adverse events" for patients who use them than equivalent drugs produced in the United States, a new study finds. These ...

The typical annual price for a newly approved prescription drug has surpassed $250,000, a new study shows, reflecting the never-ending rise in medication costs employers, consumers and taxpayers ...

Add Yahoo as a preferred source to see more of our stories on Google. Several batches of the drug did not dissolve properly, which means the person taking them would receive a lower dose.

Dr Reddy’s Laboratories has received final approval from India’s drug regulator to launch a generic version of oral semaglutide, marking its entry in the fast‑growing GLP‑1 diabetes and obesity drug ...